Companies: 10,795·Total market cap: $144.5T
Chemed Corporation

Chemed Corporation

CHENYSEHealthcare● Active
$438.70
$-2.89(-0.65%)
Market Cap$5.8B
P/E Ratio—
52W High$565.66
52W Low$365.21
Overview

Chemed Corporation (CHE) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

CHE · free cash flow · updated Jun 8, 2026

Core FCF metrics

Free cash flow was $325.5M for FY2025 (fiscal year ending 2025-12-31), down 11.5% year-over-year The FCF margin was 12.9%. Five-year CAGR stands at -5.4%.

FY2025 Free Cash Flow$325.5M▼ -11.5% YoY
Trailing 12M (TTM)$377.1Mtrailing 4 quarters sum
FCF Margin12.9%$325.5M ÷ revenue
3-Year CAGR+8.8%FY2022 → FY2025
5-Year CAGR-5.4%FY2020 → FY2025
FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

Positive FCFNegative FCF
Free Cash Flow
YoY Growth %
che free cash flow history · che free cash flow chart · che free cash flow growth rate · che free cash flow last 10 years

Annual free cash flow data

Fiscal YearFree Cash FlowYoY ChangeFCF Margin
FY2025Latest$325.5M▼ 11.5%12.9%
FY2024$368.0M▲ +34.6%15.1%
FY2023$273.4M▲ +8.3%12.1%
FY2022$252.6M▲ +1.1%11.8%
FY2021$249.9M▼ 41.9%11.7%
FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP
che free cash flow 2025 · che free cash flow 2024 · che free cash flow 2023 · che operating cash flow

FCF valuation metrics

Chemed Corporation (CHE) trades at a FCF yield of 6.43% and a price-to-free-cash-flow ratio of 16.8x. FCF per share stands at $26.19, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)
6.43%
Free Cash Flow ÷ Market Cap
per FMP freeCashFlowYieldTTM definition
FCF per Share (TTM)
$26.19
TTM FCF ÷ Shares Outstanding
Price / FCF
x16.8
Share Price ÷ FCF per Share
EV / FCF (TTM)
x16.1
Enterprise Value basis
Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31
che price to free cash flow · che free cash flow yield · che free cash flow per share · che price to cash flow ratio

Cash flow statement summary

For FY2025, Chemed Corporation generated $388.3M in operating cash flow and spent 63M in capital expenditures, yielding $325.5M in free cash flow.

Operating Activities
+$388.3M
Cash from core business operations
2025-12-31
Investing Activities
−$59.3M
CapEx, acquisitions & investments
2025-12-31
Financing Activities
−$432.8M
Buybacks, dividends & debt
2025-12-31
FCF FormulaOperating CF ($388.3M) − |CapEx| (63M) = FCF ($325.5M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →
che cash flow statement · che cash flow statement 2025 · che operating cash flow · che cash flow from operations

Free cash flow vs peers (Healthcare)

#CompanyFree Cash FlowYoY
#1
Chemed Corporation
Chemed CorporationYOU
CHE
$325.5M-11.5%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$19.70B-0.7%#3
AbbVie Inc.
AbbVie Inc.
ABBV
$17.82B-0.1%#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$16.07B-22.4%#5
Eli Lilly and Company
Eli Lilly and Company
LLY
$8.97B+2065.6%
Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Chemed Corporation (CHE) reported free cash flow of $325.5M for FY2025 (fiscal year ending 2025-12-31), down 11.5% year-over-year. The FCF margin was 12.9%.

Based on available data, Chemed Corporation has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $430.5M in FY2020. The 5-year CAGR stands at -5.4%.

Chemed Corporation's FCF yield is 6.43% and price-to-FCF ratio is 16.8x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.
RevenueFinancial statementsNet incomeEarningsForecastPrice historyMarket capCash on handP/E ratio

Frequently asked questions

CHE free cash flow · 8 questions

Chemed Corporation free cash flow was $325.5M for FY2025, down 11.5% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $377.1M.

CHE free cash flowCHE FCFCHE FCF 2025CHE free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Chemed Corporation · Chemed Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026